{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:43:23Z","timestamp":1769269403049,"version":"3.49.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T00:00:00Z","timestamp":1573776000000},"content-version":"vor","delay-in-days":2478,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1093\/annonc\/mds433","type":"journal-article","created":{"date-parts":[[2012,10,5]],"date-time":"2012-10-05T00:44:59Z","timestamp":1349397899000},"page":"428-432","source":"Crossref","is-referenced-by-count":41,"title":["Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy"],"prefix":"10.1016","volume":"24","author":[{"given":"P.","family":"Bains","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Al Tourah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Pickles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.D.","family":"Gascoyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.J.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1093\/annonc\/mds433_bb0010","doi-asserted-by":"crossref","first-page":"288","DOI":"10.6004\/jnccn.2010.0021","article-title":"NCCN clinical practice guidelines in oncology: non-Hodgkin's lymphomas","volume":"8","author":"Zelenetz","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"issue":"Suppl 5","key":"10.1093\/annonc\/mds433_bb0015","doi-asserted-by":"crossref","first-page":"v181","DOI":"10.1093\/annonc\/mdq184","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Dreyling","year":"2010","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1093\/annonc\/mds433_bb0020","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","article-title":"Long-term outcome and mortality trends in early-stage, grade 1\u20132 follicular lymphoma treated with radiation therapy","volume":"64","author":"Guadagnolo","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1093\/annonc\/mds433_bb0025","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0360-3016(88)90254-4","article-title":"Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute","volume":"14","author":"Lawrence","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1093\/annonc\/mds433_bb0030","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","article-title":"Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University","volume":"14","author":"Mac Manus","year":"1996","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1093\/annonc\/mds433_bb0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-8140(95)01600-L","article-title":"Radiotherapy results in early stage low grade nodal non-Hodgkin's lymphoma","volume":"36","author":"Pendlebury","year":"1995","journal-title":"Radiother Oncol"},{"issue":"16","key":"10.1093\/annonc\/mds433_bb0040","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1002\/cncr.25117","article-title":"Long-term outcomes for patients with limited stage follicular lymphoma: involved regional radiotherapy versus involved node radiotherapy","volume":"116","author":"Campbell","year":"2010","journal-title":"Cancer"},{"issue":"32","key":"10.1093\/annonc\/mds433_bb0045","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1200\/JCO.2008.16.0283","article-title":"Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma","volume":"26","author":"Al-Tourah","year":"2008","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.1093\/annonc\/mds433_bb0050","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1200\/JCO.2006.09.3260","article-title":"Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma","volume":"25","author":"Montoto","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mds433_bb0055","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan EL","year":"1958","journal-title":"Am Stat Assoc"},{"key":"10.1093\/annonc\/mds433_bb0060","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Assoc"},{"issue":"2","key":"10.1093\/annonc\/mds433_bb0065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/1097-0142(197908)44:2<645::AID-CNCR2820440234>3.0.CO;2-Y","article-title":"Histological transformation of non-Hodgkin's lymphoma: a prospective study","volume":"44","author":"Cullen","year":"1979","journal-title":"Cancer"},{"issue":"5","key":"10.1093\/annonc\/mds433_bb0070","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/1097-0142(19840301)53:5<1109::AID-CNCR2820530516>3.0.CO;2-O","article-title":"Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features, and prognostic implications of transformation of small cleaved cell nodular lymphoma","volume":"53","author":"Oviatt","year":"1984","journal-title":"Cancer"},{"issue":"3\u20134","key":"10.1093\/annonc\/mds433_bb0075","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10428199909050952","article-title":"Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska lymphoma study group experience","volume":"34","author":"Tezcan","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1093\/annonc\/mds433_bb0080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0609.2005.00564.x","article-title":"Follicular lymphoma in early stages: high risk of relapse and usefulness of the follicular lymphoma international prognostic index to predict the outcome of patients","volume":"76","author":"Plancarte","year":"2006","journal-title":"Eur J Haematol"},{"issue":"4","key":"10.1093\/annonc\/mds433_bb0085","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","article-title":"Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients","volume":"15","author":"Bastion","year":"1997","journal-title":"J Clin Oncol"},{"issue":"15","key":"10.1093\/annonc\/mds433_bb0090","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1182\/blood-2009-02-202465","article-title":"A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients","volume":"114","author":"Gentles","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1093\/annonc\/mds433_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2009-07-235598","article-title":"The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation","volume":"115","author":"Farinha","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1093\/annonc\/mds433_bb0100","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3324\/haematol.2009.021766","article-title":"Vascularization predicts overall survival and risk of transformation in follicular lymphoma","volume":"95","author":"Farinha","year":"2010","journal-title":"Haematologica"},{"issue":"1","key":"10.1093\/annonc\/mds433_bb0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/hon.2900080105","article-title":"Treatment of low-grade non-Hodgkin's lymphomas: assessment of doxorubicin in a controlled trial","volume":"8","author":"Lepage","year":"1990","journal-title":"Hematol Oncol"},{"issue":"18S","key":"10.1093\/annonc\/mds433_bb0110","first-page":"7510","article-title":"The impact of initial treatment of advanced stage indolent lymphoma on the risk of transformation","volume":"24","author":"Al-Tourah","year":"2006","journal-title":"J Clin Oncol, 2006 ASCO Annual Meeting Proceedings (Post-Meeting Edition)"},{"issue":"4","key":"10.1093\/annonc\/mds433_bb0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1093\/annonc\/mds433_bb0120","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1093\/annonc\/mds433_bb0125","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1470-2045(08)70002-0","article-title":"Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)","volume":"9","author":"Pfreundschuh","year":"2008","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1093\/annonc\/mds433_bb0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"issue":"11","key":"10.1093\/annonc\/mds433_bb0135","article-title":"Addition of rituximab to CHOP chemotherapy significantly improves survival of patients with transformed lymphoma","volume":"110","author":"Al-Tourah","year":"2007"},{"issue":"Suppl 4","key":"10.1093\/annonc\/mds433_bb0140","article-title":"Improved prognosis after histologic transformation (HT) of follicular lymphoma (FL): the stanford experience 1960\u20132003","volume":"19","author":"Tan","year":"2008","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419368681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419368681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/24\/2\/428\/13789205\/mds433.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T01:09:28Z","timestamp":1714439368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419368681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0923753419368681"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mds433","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}